SkinFill Gold Plus (2 x 1 ml)

Skinfill

Aesthetic injectable / dermal filler

Cross-linked hyaluronic acid dermal filler (medium concentration) \u2014 lip & facial filler

Multiple EU/European distributors list SkinFill products under Promoitalia range and indicate CE marking on reseller/wholesale portals; official CE certificate and technical documentation should be requested from manufacturer/distributor for verification.
Manufactured from non Animal origin HA by bacterial fermentation; BDDE cross Linking reported in technical summaries on reseller sites.

Multiple EU/European distributors list SkinFill products under Promoitalia range and indicate CE marking on reseller/wholesale portals; official CE certificate and technical documentation should be requested from manufacturer/distributor for verification.
Manufactured from non Animal origin HA by bacterial fermentation; BDDE cross Linking reported in technical summaries on reseller sites.

Cross-linked hyaluronic acid dermal filler (medium concentration) \u2014 lip & facial filler

Description

SkinFill Gold Plus is a cross-linked hyaluronic acid (HA) dermal filler from the SkinFill Plus line (Promoitalia) formulated for moderate volumising and correction of light to moderate wrinkles, nasolabial folds, scar filling and lip enhancement. Supplied as two 1 ml prefilled syringes per box, Gold Plus is described by distributors as a medium-consistency BDDE-crosslinked HA filler (approx. 20 mg/ml) intended for intradermal / subcutaneous injection by trained professionals.

Bnefits

Correction of light to moderate facial wrinkles and nasolabial folds.
Lip contouring and moderate lip volumisation and reshaping.
Filling of scars and small depressions to improve surface texture.
Medium viscosity gel designed for natural integration and up to ~6 months duration (as reported by resellers).
Part of the SkinFill Plus family with production by bacterial fermentation (non-animal origin) and BDDE cross-linking.

Indications

Treatment of light to moderate nasolabial folds and facial wrinkles.
Lip enhancement and contouring (shape and moderate volume restoration).
Correction of small depressions and superficial to mid-dermal volume loss.
Use as a resorbable HA filler in aesthetic facial procedures performed by qualified clinicians.

Composition

Hyaluronic acid, cross-linked (reported concentration: 20 mg/ml, BDDE as cross-linking agent).
Phosphate buffer (pH ~7.0) and other excipients typical of HA fillers (specific excipient lists vary by batch/packaging and are not fully published on all reseller pages).
Sterile, non-pyrogenic product of non-animal origin (bacterial fermentation).

Formulation

Prefilled sterile glass syringe(s) containing cross-linked hyaluronic acid gel (medium consistency) for injection. Available as 2 × 1 ml syringes per box on many distributor listings.

Packaging

Box containing 2 prefilled syringes of 1 ml each (total 2 ml per pack) — common packaging format reported by multiple distributors.
Some packs are listed with additional needles (varies by distributor).

Usage

To be administered only by trained and licensed medical professionals experienced in injectable fillers.
Injection technique (needle vs cannula), depth (intradermal/subcutaneous), and volume per site are determined by clinician based on indication and patient anatomy.
Follow standard aseptic technique and local protocols for dermal filler injections, patient consent, and post-procedure aftercare.
Post-treatment advice typically includes avoiding strenuous exercise, excessive heat, alcohol and massaging the treated area for the first 24–48 hours (clinic standard practice).

Contraindications

Contraindications are not exhaustively published on every reseller page. Standard contraindications for HA dermal fillers apply, including active infection or inflammation at the proposed injection site, known hypersensitivity to any component of the product (including cross-linking residues), pregnancy and breastfeeding (commonly listed by resellers), and use in minors. Clinicians must consult official product labelling supplied with each batch for full contraindications.

Adverse Effects

Public reseller/manufacturer summaries do not provide a detailed adverse-event list on every page. Typical expected local, transient reactions include pain, swelling, bruising, erythema, tenderness, nodules and possible temporary asymmetry. Rare but serious complications (vascular occlusion, infection, granulomatous reaction) are known risks with injectable fillers and are managed per clinical protocols. Patients must receive full safety counselling prior to treatment.

Storage Conditions

Store at controlled room temperature away from direct heat and sunlight as per distributor listings. Exact storage temperature range should be confirmed in the product leaflet/IFU included in the supplied packaging.

Duration

Distributor pages commonly report clinical effect lasting ~6 months (range may vary by patient, indication and product lot); maintenance treatments typically required to sustain cosmetic effect.

Onset

Immediate volumising/contour improvement observed after injection; full tissue integration and optimal aesthetic result typically seen over days as swelling subsides.